Esperion Therapeutics Inc
ESPR2.530USD
+0.075+3.05%
收盘 10/10, 16:00（美东）报价延迟15分钟
506.39M总市值
亏损市盈率 TTM
关于 Esperion Therapeutics Inc 公司
Esperion Therapeutics, Inc. 是一家制药公司。该公司专注于开发和商业化口服、每日一次、非他汀类药物，用于治疗低密度脂蛋白胆固醇 (LDL-C) 升高的患者。该公司的产品包括 NEXLETOL、NEXLIZET、NILEMDO 和 NUSTENDI。该公司的 NEXLETOL 和 NEXLIZET（贝培多酸和依折麦布）片剂是口服、每日一次、非他汀类药物，用于治疗患有杂合子家族性高胆固醇血症 (HeFH) 或动脉粥样硬化性心血管疾病 (ASCVD) 的成人原发性高脂血症。其 NEXLETOL 是一种 ATP 柠檬酸裂解酶 (ACL) 抑制剂，可通过减少胆固醇生物合成和上调 LDL 受体来降低 LDL-C。其 NUSTENDI 含有贝培多酸和依折麦布，通过互补作用机制抑制肝脏胆固醇合成和肠道吸收，从而降低升高的 LDL-C。其在研产品包括下一代 ACLYi。
Esperion Therapeutics Inc简介
公司代码ESPR
公司名称Esperion Therapeutics Inc
上市日期Jun 24, 2013
CEOMr. Sheldon L. Koenig
员工数量304
证券类型Ordinary Share
年结日Jun 24
公司地址3891 Ranchero Drive, Suite 150
城市ANN ARBOR
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编48108
电话17348873903
网址https://www.esperion.com/
公司代码ESPR
上市日期Jun 24, 2013
CEOMr. Sheldon L. Koenig
Esperion Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sheldon L. Koenig
Mr. Sheldon L. Koenig
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
249.81K
-10.22%
Mr. Benjamin (Ben) Halladay
Mr. Benjamin (Ben) Halladay
Chief Financial Officer
Chief Financial Officer
76.46K
-8.44%
Mr. Stephen C. Rocamboli, J.D.
Mr. Stephen C. Rocamboli, J.D.
Independent Director
Independent Director
69.26K
+91.01%
Ms. Tracy M. Woody
Ms. Tracy M. Woody
Independent Director
Independent Director
33.57K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
5.28K
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Ms. Alina Venezia
Ms. Alina Venezia
IR Contact Officer
IR Contact Officer
--
--
Mr. J. Martin (Marty) Carroll
Mr. J. Martin (Marty) Carroll
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Benjamin O. Looker, Esq.
Mr. Benjamin O. Looker, Esq.
General Counsel
General Counsel
--
--
Mr. Jay P. Shepard
Mr. Jay P. Shepard
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Sheldon L. Koenig
Mr. Sheldon L. Koenig
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
249.81K
-10.22%
Mr. Benjamin (Ben) Halladay
Mr. Benjamin (Ben) Halladay
Chief Financial Officer
Chief Financial Officer
76.46K
-8.44%
Mr. Stephen C. Rocamboli, J.D.
Mr. Stephen C. Rocamboli, J.D.
Independent Director
Independent Director
69.26K
+91.01%
Ms. Tracy M. Woody
Ms. Tracy M. Woody
Independent Director
Independent Director
33.57K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
5.28K
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.80%
The Vanguard Group, Inc.
5.05%
Wasatch Global Investors Inc
4.45%
Two Seas Capital LP
4.29%
PenderFund Capital Management, Ltd.
2.88%
其他
77.54%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.80%
The Vanguard Group, Inc.
5.05%
Wasatch Global Investors Inc
4.45%
Two Seas Capital LP
4.29%
PenderFund Capital Management, Ltd.
2.88%
其他
77.54%
股东类型
持股股东
占比
Investment Advisor
22.23%
Investment Advisor/Hedge Fund
14.79%
Hedge Fund
11.32%
Research Firm
1.86%
Individual Investor
0.52%
Bank and Trust
0.21%
Pension Fund
0.14%
Insurance Company
0.04%
其他
48.88%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
362
102.06M
50.63%
-53.58M
2025Q2
382
118.70M
59.89%
-48.77M
2025Q1
406
120.12M
60.62%
-48.61M
2024Q4
416
132.03M
67.01%
-41.92M
2024Q3
411
131.82M
67.24%
-43.99M
2024Q2
396
139.50M
73.71%
-8.75M
2024Q1
381
127.67M
67.51%
+27.09M
2023Q4
370
73.40M
64.38%
-30.67M
2023Q3
392
79.14M
69.19%
-24.19M
2023Q2
397
76.08M
79.96%
-27.32M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
13.45M
6.67%
+118.96K
+0.89%
Jun 30, 2025
The Vanguard Group, Inc.
11.72M
5.81%
+229.10K
+1.99%
Jun 30, 2025
Wasatch Global Investors Inc
10.34M
5.13%
-591.00K
-5.41%
Jun 30, 2025
Two Seas Capital LP
9.95M
4.94%
+3.02M
+43.63%
Jun 30, 2025
PenderFund Capital Management, Ltd.
6.68M
3.31%
+4.68M
+233.83%
Jun 30, 2025
Marshall Wace LLP
5.31M
2.63%
+1.68M
+46.22%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.58M
2.27%
+137.69K
+3.10%
Jun 30, 2025
Two Sigma Investments, LP
3.92M
1.95%
-1.34M
-25.42%
Jun 30, 2025
Meditor Capital Management Limited
3.79M
1.88%
--
--
Sep 30, 2024
State Street Global Advisors (US)
3.76M
1.86%
-789.53K
-17.36%
Jun 30, 2025
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
1.05%
iShares Micro-Cap ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.04%
Principal U.S. Small-Cap ETF
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
ProShares Hedge Replication ETF
0.02%
Global X Russell 2000 ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比1.05%
iShares Micro-Cap ETF
占比0.09%
ProShares Ultra Nasdaq Biotechnology
占比0.04%
Invesco Nasdaq Biotechnology ETF
占比0.04%
Principal U.S. Small-Cap ETF
占比0.04%
Invesco RAFI US 1500 Small-Mid ETF
占比0.03%
ProShares Hedge Replication ETF
占比0.02%
Global X Russell 2000 ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
